Cracking the Code: Essential Psychiatry Concepts for Your FNP Boards

Psychiatry · 6 min read · July 9, 2026

Cracking the Code: Essential Psychiatry Concepts for Your FNP Boards

Hello future FNPs! Psychiatry is often an area that gives students pause, and for good reason—the human mind is incredibly complex. But when it comes to your FNP board exams, you don't need to be a psychiatrist; you need to be a competent, safe, and effective primary care provider who can identify, manage, and refer mental health conditions appropriately. The good news? The boards focus on high-yield, common presentations and first-line management. Let's demystify some of these crucial topics so you can approach your exam with confidence.

Understanding Common Mood Disorders: Depression and Bipolar

Mood disorders are among the most frequently encountered mental health conditions in primary care, and they are definitely high-yield for your boards. Knowing the diagnostic criteria and initial management is key.

Major Depressive Disorder (MDD)

MDD is characterized by a persistent sad mood or anhedonia (loss of interest or pleasure) for at least two weeks, accompanied by at least four additional symptoms. Remember the mnemonic SIGECAPS for these symptoms:

Sleep changes (insomnia or hypersomnia)
Interest (loss of interest or pleasure)
Guilt or feelings of worthlessness
Energy (fatigue or loss of energy)
Concentration (decreased ability to concentrate or indecisiveness)
Appetite changes (increase or decrease) or weight changes
Psychomotor agitation or retardation
Suicidal ideation or thoughts of death

First-line pharmacotherapy for MDD typically involves SSRIs (Selective Serotonin Reuptake Inhibitors) like sertraline, escitalopram, citalopram, or fluoxetine. Remember to start low and go slow, and educate patients about the delayed onset of action (2-4 weeks) and potential side effects.

Bipolar Disorder

Bipolar disorder involves episodes of both depression and mania (or hypomania). The key to diagnosis is identifying the manic or hypomanic episode.

Mania: A distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy, lasting at least one week and present most of the day, nearly every day. It must cause marked impairment in social or occupational functioning or necessitate hospitalization.
Hypomania: Similar symptoms but lasting at least four consecutive days, and the episode is not severe enough to cause marked impairment or hospitalization.

Clinical Pearl: When a patient presents with depressive symptoms, always screen for a history of mania or hypomania before initiating an antidepressant. Prescribing an antidepressant alone to someone with undiagnosed bipolar disorder can precipitate a manic episode. If bipolar disorder is suspected, mood stabilizers like lithium, valproate, or lamotrigine are the first-line treatment, often in combination with an atypical antipsychotic.

Anxiety Disorders: GAD, Panic, and Social Anxiety

Anxiety disorders are also extremely common and present in various ways. The boards will test your ability to differentiate them.

Generalized Anxiety Disorder (GAD)

GAD is characterized by excessive worry and anxiety about multiple events or activities for at least six months, accompanied by at least three of the following symptoms:

Restlessness or feeling on edge
Being easily fatigued
Difficulty concentrating
Irritability
Muscle tension
Sleep disturbance

Panic Disorder

Panic disorder involves recurrent, unexpected panic attacks. A panic attack is an abrupt surge of intense fear or discomfort that reaches a peak within minutes, during which time four or more specific symptoms occur (e.g., palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, fear of losing control or dying).

Social Anxiety Disorder

This involves marked fear or anxiety about social situations in which the individual is exposed to possible scrutiny by others. The individual fears they will act in a way that will be negatively evaluated. This fear is out of proportion to the actual threat and lasts for at least six months.

First-line treatment for most anxiety disorders (GAD, Panic, Social Anxiety) is often SSRIs, combined with psychotherapy (especially Cognitive Behavioral Therapy - CBT). Benzodiazepines (e.g., lorazepam, alprazolam) can be used for short-term, acute symptom relief but are not first-line for chronic management due to dependence risk. Buspirone is an alternative for GAD that is non-addictive and can be used long-term.

Board Tip: Remember that SSRIs are the workhorse for both depression and most anxiety disorders. If you see a question about first-line pharmacotherapy for either, SSRIs are a strong contender. Always consider the patient's individual history and comorbidities.

Psychotic Disorders: Schizophrenia

While primary care FNPs typically refer patients with suspected or diagnosed psychotic disorders to psychiatry, you must be able to recognize the signs and symptoms and understand initial stabilization principles.

Schizophrenia is a chronic, severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. Diagnosis requires two or more of the following symptoms, present for a significant portion of time during a one-month period (with at least one being delusions, hallucinations, or disorganized speech):

Delusions: Fixed, false beliefs (e.g., paranoia, grandiosity).
Hallucinations: Perceptual experiences without an external stimulus (e.g., auditory, visual).
Disorganized speech: Incoherence, frequent derailment.
Grossly disorganized or catatonic behavior.
Negative symptoms: Diminished emotional expression, avolition (lack of motivation), alogia (poverty of speech).

Symptoms must be present for at least six months, including prodromal or residual periods where only negative symptoms or attenuated positive symptoms are present.

Management: The mainstay of treatment is antipsychotic medication. These are categorized as first-generation (typical) and second-generation (atypical) antipsychotics. Atypical antipsychotics (e.g., risperidone, olanzapine, quetiapine, aripiprazole) are generally preferred due to a lower risk of extrapyramidal symptoms (EPS) and tardive dyskinesia, though they carry a higher risk of metabolic side effects (weight gain, dyslipidemia, hyperglycemia).

Clinical Pearl: When managing patients on atypical antipsychotics, remember to monitor metabolic parameters regularly (weight, waist circumference, fasting glucose, lipid panel) due to the increased risk of metabolic syndrome. This is a common board question and a critical primary care responsibility.

Key Takeaways for Your Boards

Diagnostic Criteria: Know the duration and key symptoms for MDD, GAD, Bipolar (mania/hypomania), and Schizophrenia. Pay attention to the timeframes (2 weeks, 4 days, 6 months). These are often tested directly.
First-Line Treatments: SSRIs for depression and most anxiety disorders. Mood stabilizers for bipolar. Atypical antipsychotics for schizophrenia. Know common side effects and monitoring.
Safety First: Always assess for suicidality in any patient presenting with depressive symptoms. If positive, determine the level of risk and intervene appropriately (safety plan, referral to emergency services).

Psychiatry on your FNP boards isn't about memorizing every nuance, but about understanding the core presentations, making appropriate initial diagnoses, and knowing your first-line management and referral guidelines. You've got this! Keep practicing, keep reviewing, and trust in your ability to become an outstanding FNP.

Ready to solidify your knowledge and conquer your FNP boards? Visit The FNP Review for comprehensive board prep resources, including a robust QBank with detailed rationales to help you master these concepts and more.